Taysha Gene Therapies (TSHA) Reports Initial Clinical Data f

Taysha Gene Therapies (TSHA) Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial

Taysha Gene Therapies (TSHA) Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , Seanp Nolan , Elsa Rossignol , Hayleigh Collins , Exchange Commission , Ut Southwestern Gene Therapy Program , Data Monitoring Committee , Nasdaq , B Group Capital , Head Of Corporate Communicationstaysha Gene Therapies Inc , Carolyn Hawleycanale Communications , European Commission , Taysha Gene Therapies Inc , Service Revenue , Company Contact , Development Expenses , Taysha Gene Therapies , Responsive Auto Regulatory Element , Chief Executive Officer , Disease Progression Model , Associate Professor Neuroscience , Principal Investigator , Venrock Healthcare Capital Partners , Acuta Capital Partners , Kynam Capital Management , Octagon Capital , Global Investments , Orphan Drug , Rare Pediatric Disease , Clinical Global Impressions Scale , Rett Syndrome Hand Function Scale , Revised Motor Behavior Assessment , Rett Syndrome Behavior Questionnaire , Global Impressions , Syndrome Behavior Questionnaire , Independent Data Monitoring Committee , Administrative Expenses , Private Placement , Gene Therapies , Gene Therapy , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Inc Condensed Consolidated Balance Sheet Data , Inc Condensed Consolidated Statements , Hayleigh Collins Director , Corporate Communicationstaysha Gene Therapies ,